Skip to main content

and
  1. No Access

    Article

    Bloodspot acylcarnitine and amino acid analysis in cord blood samples: efficacy and reference data from a large cohort study

    In order to test the feasibility of cord blood screening for inherited metabolic disease, a two-year cohort study of births in six obstetric units from five towns in the north of England was undertaken. These ...

    J. H. Walter, A. Patterson, J. Till in Journal of Inherited Metabolic Disease (2009)

  2. Article

    Open Access

    Erratum: The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro

    Correction to: British Journal of Cancer (2008) 98, 1085–1093. doi:10.1038/sj.bjc.6604281 During revision and subsequent submission of the above paper to the journal, an author's name, Rajmohan Murali, was omi...

    P M O'Brien, M J Davies, J P Scurry, A N Smith, C A Barton in British Journal of Cancer (2008)

  3. Article

    Open Access

    The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro

    Despite a high initial response rate to first-line platinum/paclitaxel chemotherapy, most women with epithelial ovarian cancer relapse with recurrent disease that becomes refractory to further cytotoxic treatm...

    P M O'Brien, M J Davies, J P Scurry, A N Smith, C A Barton in British Journal of Cancer (2008)

  4. No Access

    Article

    Carnitine transporter defect: Diagnosis in asymptomatic adult women following analysis of acylcarnitines in their newborn infants

    Carnitine transporter defect (CTD) is an autosomal recessive disorder characterized by episodes of non-ketotic hypoglycaemia, hyperammonaemia and liver disease, or by the development of cardiomyopathy, both of...

    S. Vijay, A. Patterson, S. Olpin, M. J. Henderson in Journal of Inherited Metabolic Disease (2006)

  5. No Access

    Article

    Heterogeneity of symptomatology in two male siblings with thymine uraciluria

    M. J. Henderson, S. Jones, P. Walker, J. Duley in Journal of Inherited Metabolic Disease (1995)

  6. No Access

    Article

    5-Oxoprolinuria associated with 5-oxoprolinase deficiency; further evidence that this is a benign disorder

    M. J. Henderson, A. Larsson, B. Carlsson in Journal of Inherited Metabolic Disease (1993)

  7. No Access

    Article

    Dihydropyrimidinase deficiency presenting in infancy with severe developmental delay

    M. J. Henderson, K. Ward, H. A. Simmonds in Journal of Inherited Metabolic Disease (1993)

  8. No Access

    Chapter and Conference Paper

    Dihydropyrimidinuria Presenting in Childhood with Severe Developmental Retardation

    Dihydropyrimidinase (5,6-dihydropyrimidine amidohydrolase; EC 3.5.2.2), is the second enzyme involved in the breakdown of the pyrimidine bases uracil and thymine and catalyses the degradation of dihydrouracil ...

    K. Ward, M. J. Henderson, H. A. Simmonds in Molecular Genetics, Biochemistry and Clini… (1993)

  9. No Access

    Chapter and Conference Paper

    Economical computer integrated manufacturing

    Use of Personal Computers and Local Area Network technology to provide a low cost integrated solution for CIM applications. This paper ex amines the historical development of CIM and the current state of the a...

    M. J. Henderson in Proceedings of the 5th International Confe… (1986)

  10. No Access

    Article

    Further observations in a case of uridine diphosphate galactose-4-epimerase deficiency with a severe clinical presentation

    The red-cell concentrations of galactose-1-phosphate and uridine diphosphate galactose have been studied in relation to dietary galactose in a case of uridine diphosphate galactose-4-epimerase deficiency (McK ...

    M. J. Henderson, J. B. Holton, R. MacFaul in Journal of Inherited Metabolic Disease (1983)